/geneseeq-study-highlights-ctdna-monitoring-clinical-value-in-colorectal-cancer-patients-resistant-to-braf-egfr-targeted-therapy/ We see precision medicine as the future of cancer care. Let’s accelerate precision cancer care, together. Tue, 18 Oct 2022 14:49:50 +0000 hourly 1 https://wordpress.org/?v=6.9.4